CA1211254A - Suture rings for heart valves - Google Patents
Suture rings for heart valvesInfo
- Publication number
- CA1211254A CA1211254A CA000444640A CA444640A CA1211254A CA 1211254 A CA1211254 A CA 1211254A CA 000444640 A CA000444640 A CA 000444640A CA 444640 A CA444640 A CA 444640A CA 1211254 A CA1211254 A CA 1211254A
- Authority
- CA
- Canada
- Prior art keywords
- ring
- retainer ring
- protrusion
- deformable
- suture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
Abstract
SUTURE RINGS FOR HEART VALVES
ABSTRACT OF THE DISCLOSURE
Suture rings are provided for heart valves having surrounding stiffening protrusions that are either integral parts of the heart valve bodies or are rigid rings held in interference fit within peripheral grooves of heart valve bodies. Metal retainer rings engage the stiffening protrusions to lock the retainer rings to the valve bodies and carry fabric coverings on their exterior surfaces that are suturable to the heart tissues. Deformable portions of the retainer rings are used to provide engagement between the retainer rings and the protrusions and also to permanently position bands that secure the fabric coverings to the retainer rings.
ABSTRACT OF THE DISCLOSURE
Suture rings are provided for heart valves having surrounding stiffening protrusions that are either integral parts of the heart valve bodies or are rigid rings held in interference fit within peripheral grooves of heart valve bodies. Metal retainer rings engage the stiffening protrusions to lock the retainer rings to the valve bodies and carry fabric coverings on their exterior surfaces that are suturable to the heart tissues. Deformable portions of the retainer rings are used to provide engagement between the retainer rings and the protrusions and also to permanently position bands that secure the fabric coverings to the retainer rings.
Description
o~
SUTURE RINGS FOR HEART VALVES
The present invention relates to heart valve prostheses and more particularly to improved suture rings for implantin~ heart valves.
~
Artificial heart valves for suryical implantation in the human heart are check valves which permit blood flow through the valves in a downstream direction but block regurgitation of olood in a reverse or upstream direction. In spite of the rela~ively simple concept of a check valve, much effort has been exerted in improving the design of heart valves which are implanted into the human heart and should desirably function reliahly for a lifetime.
Heart valves having pivoting valve members, either in the form of a single occluder, such as described in U.S. Patent No. 4,123,805, or a pair of leaflets, such as described in U.S. Patent No.
4,254,50~, provide yood flow characteristics and quick response to blood flow. As a means for inserting heart valves into the hear~, they commonly have attached fabric members suturable to the tissues of ~he heart.
Frequently the fabric member is attached to a separate suture ring which is applied to the periphery of the hear~ valve body or orifice ring, for example, as described in U~S. Paten~ No~ 3,763,548. An important design consideration for heart valves and their suture rings is minimizing their thickness in a radial ; direction in order to maximize the size of the blood flow passageway of the heart valve that is inserted in a natural passageway of a given size. Newer, thinner heart valve bodies formed, for example, as unitary structures of pyrolytic carbon have enabled larger valve passageways to be provided; however, thin heart valve bodies sometimes lack the rigidity that is desirable for such valves.
. \", '~'~
,. \
In some cases, deformability of the heart valve body is advantageous as where the occluder and valve body have cooperating depressions and protruslons and the resiliently deformable valve body is deformed to permit insertion of the occluder and ~he resilient valve body is allowed ~o spring back into engagement with the occluder. In other instances, engayement of the occluder with the valve body may be accomplished by deformation of the occluder or by other means. In any case, deformability of the valve body is undesirable in an assembled heart valve. ~lthough after insertion into the heart, the valve is not subjected to substantial deforming Eorces, the possibility remains that a surgeon could inadvertantly deform the orifice ring and dislocate the occluder as he is inserting the valve into the heart. The heart valve body in combination with the suture ring should therefore provide sufficient - resistance to deformation that there is no danger of displacing the occluder during insertion into the heart.
The need continues for improved suture rings which together with the heart valve bodies occupy a narrow region along the heart passageway and which toge~her provide the rigidity needed to assure that ~he ; valve body will not be deformed during insertion. The fabric member portion of the suture ring should be continuous, fully covering any exposed metal portions of a suture ring, and exposed seams and fabric ends are to be avoided.
SUMMARY OF THE INVENTION
; 3~ Sutue rings, having fabric coverings for suturing to the heart tissues~ are provided that lock onto protrusions which surround orifice rings of heart valves adding stiffness thereto. The suture rings have inner surfaces which overlie outer surfaces of the protrusion, first end portions which engage one end surface of the protrusion and second end portions which . ~
are deformable to engage the opposite end surfaces of the protrusions. The fabric coverings are secured to the retainer rings with bands, and deformable sections of the retainer ring permanently position the banas in place along the retainer ring.
In a specific embodiment, the protrusion on which the retainer ring is locked is an outwardly extending portion of a stiffener ring received in interference fit in a peripheral groove of the orifice ring.
Brief Description of the Drawi_~
FIGURE 1 is a perspective view of a bileaflet heart valve and a suture ring assembly, embodying various features of ~he invention, for insertion in a mitral location;
FIGURE 2 is an exploded perspective view of the suture ring assembly;
FIGURE 3 is an enlarged cross-sectional view of the suture ring of FIGURE 2 in a condition nearly ready for mating with the heart valve;
FIGURE 4 is an enlarged frag~entary cross-sectional view similar to FIGURE 3 illustrating mating of the assembly with the heart valve;
FIGURE 5 is an enlarged cross-sectional view taken generally along line 5-5 of FIGURE l;
FIGURE 6 is a perspective view of a heart valve having a single disc occluder and an alternative embodiment of a suture ring assembly, embodying various features of the invention, for insertion in an aortic location;
FIGURE 7 is an exploded perspective view of the suture ring assembly and heart valve body of FIGURE 6;
FIGURE 8 is an enlarged cross-sectional view of the suture ring of FIGURE 6 preparatory to mating with the heart valve body;
~4--FIGURE 9 is an enlarged fraymentary cros~-sectional view, similar to FIGURE 8, showing the valve body slipped into the prepared suture ring of FIGURE 8; and FIGURE 10 is an enlarged cross-sectional view taken along line 10-10 of FIGURE 6.
Detailefl Description of the Preferred Embodiment Illustrated in FIGURE 1 is a heart valve 11 which carries a suture ring assembly 13 particularly adapted for insertion in a mitral location. The suture ring assembly has an outer covering 15 of porous fabric which can be sutured to the tissue of the heart and to which the fibrous tissues of the heart will attach during healing.
The illustrated hear~ valve 11 has two leaflets or valve members, such as described in the above-mentioned '508 Patent in which a pair of generally semi-circular leaflets 17 are mounted within an orifice ;~ ring or valve body 19 for pivoting between an open ,! 20 position to allow blood flow through the orifice or ~` passageway and a closed position to block blood flow.
The leaflets 17 are mounted in the orifice ring by I suitable interengagement means (not shown) which may `~ include depressions and/or protuberances on the interior of the orifice ring and cooperating depressions and/or protuberances at the periphery of each leaflet 7 which interengagement means forms no part of the present ~: invention.
Such orifice rinqs are often formed of materials that are somewhat resiliently deformable in order to be deformed for insertion of the valve members 17. When the orifice ring 19 returns to its annular configuration, the depressions and/or protrusions of the orifice ring and valve members 17 mount the valve - 35 members for pivotal motion. ~ particularly suitable , material for formation of valve members and orifice :;' ., z~
rings is pyrocarbon, such as that sold under the trademark PYROLITE, which has a surface with highly thromboresistant characteristics. Orifice rings formed of pyrocarbon or of materials such as graphite coated with pyrocarbon may be deformed sufEiciently for mounting of the valve members.
Heart valves 11 generally have orifice rings 19 with shallow outwardly facing annular yrooves 23. In accordance with one aspect of the present invention, the suture ring assembly 13 includes an inner stiffener ring 25, which interfits with the annular groove and stiffens the orifice ring against deforma~ion during surgical implantation, an outer surrounding retainer ring 33 and a fabric member 31 which is suturable to the tissues of the heart. An inner surface 27 of the stiffener ring 25 is held in interference fit within the shallow annular groove 23, and the thickness of the ring is such that its outer surface 29 extends radially outward of the outer surface of the orifice ring. The retainer ring 33 has an interior region or groove 34 which accommodates the outwardly protruding portion 28 o the stiffener ring 25 with a fabric member 31 interposed and held therebetween.
The fabric member 31, which is initially tubular in shape, is wrapped into a closed loop configuration around the retainer ring 33 with its ends 35a, 35b joined together to form the cover 15 which fully surrounds the retainer ring, and the junction between the overlapping ends 35 of the tubular fabric member is locked into a non-exposed position~ Enclosure of the junction is achieved by a deformable section comprised of a ring of tines 41 that extend from a rigid annulus 43 of the retainer ring and are crimped into a curved configuration around the junction.
Generally, the application of the suture ring assembly 13 to the heart valve is as follows. The stiffener ring 25, which is formed of metal, is shrink-Eitted into an interference fit within the outwardly facing groove 23 by first heating it to expand its diameter. The fabric member 31 is wrapped into its closed loop configuration around the retainer ring 33 and its ends are joined with a pair of cords or ties, one tie 37a banded around a first end 35a and a second tie 37b banded around the second end 35b~ The ring of tines 41, which have been partially pre-crimped outward (as shown in FIG. 3), are further crimped toward the annulus 43 to lock in the ties and surrounding fabric.
The fabric covered retainer ring 33, is thereafter snapped onto the stiffener ring 25 by means of a deformable segment consisting of a ring of resilient prongs or tangs 45 that ex~end from the annulus 43 in the opposite direction from the tines 41.
So that the invention may be more fully understood, the suture ring assembly will now be described in greater detail. Although it is understood that ~he heart valve and suture ring assembly will be oriented within the heart valve in the orientation of the replaced natural heart valve, for ease of explanation, the vertical orientation of the several members will be described with reference to FIGURES 1 5 of the drawings.
The stiffener ring 25 is of annular shape ; having a generally rectangular cross section; however, the upPer outer edge 47 is chamfered to facilitate application of the retainer ring 33 as described hereinbelow. The inner surface 27 of the stiffener ring is generally matched to the shape of the shallow groove 23 of the orifice ring 19 with the inside diameter of the stiffener ring substantially equal to the root diameter of the groove and the height of the ~tiffener ring substantially equal to that of the groove. The thickness o~ the stiffener ring is greater than the r depth of the groove so that the outer surface 28 of the ring protrudes radially outward of the orifice ring 19.
As a means of fitting the stiffener ring 25 over one end of the orifice ring 19 and into the groove 23, the stiffener ring is first heated to high temperatures until it expands sufficiently to slide over the ring. The heat-expanded stiffener ring is positioned around the groove and cooled to ambient temperatures whereat it seats snugly in the groove~ The metal of which the stiffener ring is formed has a coefficient of ~hermal expansion sufficient to permit i~s application, when hea~ed, to the orifice ring.
Although the stiffener ring in the final assembly is shielded by the fabric covering 15 from contac~ with blood or tissue, the metal used to form the stiffener ring is selected for biocompatibility and thromboresistance. A Co-Cr alloy is a preferred material for formation of the stiffener ring which may ; be heated to about 900F for application to the orifice ring.
The retainer ring 33 is fabricated as a ; unitary, generally tubular piece of metal appropriately ~ slit to provide the rings of tines 41 and tangs 45 - extending in opposite directions from the central annulus 43. Although the retainer ring is fully covered with fabric in the complete heart valve-s~iffener ring-retainer ring assembly, the metal is also selected for biocompatibility and ~hromboresistanceO The central portion of the metal retainer ring has a thickness sufficient that it will not deform under the conditions of suture ring assembly. The tangs 45 are less thick and in the process of suture ring assembly will deflect~
but the "memory~ of the resilient metal returns the tangs to their original configuration. The tines 41 are relatively thin and are deformed past their elastic limit and during suture ring assembly assume the shape 5~
into which they are deformed. A preferred ~etal for fabrication of the retainer ring is titanium. Other metals, such as stainless steel, may also be used to ~ fabricate ~he retainer ring, or a material having similar deformable properties might be used instead of metal.
The central annulus 43 is relatively thick giving shape and rigidity to the retainer ring 33. The inner surface 51 of the annulus has a diameter slightly greater than the outer diameter of the orifice ring to accommodate a layer of fabric therebetween.
Below the central annulus 43, the inwardly facing annular groove or region 34 is formed to accommodate the outwardly protruding portion 28 of the ' 15 stiffener ring 25 leaving a lower annular ri~ 44. The groove 34 is proportioned to accommodate a ~ingle layer , of the tubular fabric member 31 interposed between the stiffener ring and the retainer ring along an upper surface or overhang 57, a vertical surface 59 and a lower surface 65 of the groove.
To facilitate interconnection of the retainer ring and the orifice ring-stiffener ring assembly, the retainer ring 33 is divided by a plurality of slits 55 into the ring of resilient tangs 45 extending downward from the central annulus 43. The lower rim 44 is divided by the slits S5 into radially inwardly extending . lugs Sl at the ends o the tangs 45. Preferably, the ;; under~urfaces 63 of the lugs 61 are rounded to ` facilitate camming of the lugs over the upper surface 64 and the outer surface 29 of the stiffener ring 25 during mating of the retainer ring to ~he orifice ring-stiffener ring assemblyO ~etween the lugs 61 and the annulus~ the thickness of the tangs 45 is such to allow them to deform outwardly during retainer ring application and snap back thereaFter to surround and engage the stiffener ring.
":;
, .
..Z~
Above the annulus 43, a thin tubular portlon 67 of the retainer ring 33 is divided by a plurality of slits 68 into the ring of tines 41~ The thin tine~ are deormed past their elastic limit upon the applicatlon of sufficient crimping force thereto. The tines 41 are precrimped prior to application of the fabric member, using suitable dies, into the outwardly curved configuration seen in FIGURE 3, and the precrimped tines, along with an outwardly extending flange 71 of the annulus 43, provide an outwardly facing annular region 79.
The fabric member 31 is formed of fabric selected for lifetime durability as well as compatibility with blood and heart tissue. A woven or knitted fabric provides porosity for ingrowth of ~eart tissue, and a preferred material for the fabric member is Dacron knit fabric. The length of the tubular fabric member is sufficient to fully surround the retainer ring closely following its contours as well as providing a radially extending flap 75 for suturing to the heart tissue.
To facilitate handling and suturing, it is preferred that the flap 75 be thickened, and this is preferably ~ccomplished by means of a resilient polymeric filler ring 76, e.g., formed of low density or foanl polytetrafluoroethylene, such as that sold under the trademark Teflon. The filler ring has a semi-elliptical cross section, its inner surface 78 being substantially vertical and having a diameter match2d to the outside diameter of the finally crimped tines 41 as seen in FIG. 5. ~he Teflon Eiller rinq 76 is easily penetrated by suturing needles. Alternatively, the flap could be thickened using a longer fabric member 31 and folding and layering its ends, but the close knit oE the fabric makes it difficult for suturing nee-lles to penetrate multiple layers~
.~.
-h~
The tubular fabric member 31 is wrapped around the re~ainer ring 33 prior to its appllcation to the orifice ring 19 and fitted stiffener ring 25. The fabric member 31 is shown in FIGURE 2 in its simple tubular configuration; however, prior to applicatioll to the retainer ring, the fabric member is preferably pre-creased, e.g., by steam pressing, in order to closely conform to the shape of the retainer ring which it is to cover. Various dies are used in pre~creasing the fabric member to conform to the contours of the retainer ring. The fabric is creased to follow the contours of inwardly facing annular region 34. On the outside of the retainer ring, a segment of the fabric stretches from the undersurface 63 of the lugs to the upper surface of the central portion of the retainer ring 33.
Within the outwardly facing annular region 79 provided by the precrimped tines 41, the first or lower end 35a of the fabric member is securely tied with one of the suture cords 37a leaving a short length 81 of the first end extending beyond the point of tying. The outwardly curved tines prevent upward displacement of the tightly tied cord. The filler ring 76 is t'nen placed around the ring of precrimped tynes 41, its inner surface 78 being deformed by the tines which have not yet been fully crimped, as seen in FIG. 3. The second or upper end of the fabric member 31 is brought arounA
the filler ring 76, tucked below the tines 41 and tied tightly with the second cord 37b within the annular region 79. The second end overlaps the first end completing the closed loop configuration of the fabric covering 15. The free terminus 83 o the second end extending beyond the tie is folded back upon itself into the region radially exterior of the two ties so it lies along the free length 81 o the first end leaving no ` exposed fabric ends to fray or interfere with the flow .
of blood. In order that the second cord may be knotted, its ends may be threaded through the fa~ric and tied exterior of the closed fabric loop. The cords maintain the fabric in position along the retainer ring and filler ring 76. The tines 41 are then crimped to their final configuration so they extend substantially back to the flange 71 of the annulus 43, locking the cords 37 and fabric end portions in the annular region 79 ~etween the crimped tines and the flange.
The loose multilayered flap 75 of the fabric member is steam-pressed for the final time in~o a flat annular configuration extending radially outward of the upper end of the retainer ring for suturing to the heart tissues and in particular to the tissue at the interior of a passageway remaining after excision of a natural mitral valve. The fabric-covered suture ring at this stage may be coated with vapor-deposited carbon, 5uch as that sold under the trademark Biolite, giving the exposed fabric a highly thromboresistant surface.
The covered, coated retainer ring i5 ready for application to the heart valve-stiffener ring assembly.
The retainer ring is pressed downward over the orifice ring-stiffener ring assembly as seen in FIGURE 4. When the lower curved surfaces 63 of the tang lugs 61 contact the chamfered upper edge 47 of the stiffener ring, the tangs 45 resiliently deform outwardly, and when the flat upper surfaces 65 of the lugs reach the bottom edge of the stiffener ring, the tangs spring ~ack inward locking the retainer ring in surrounding relationship about the stiffener ring. With the horizontal upper surface 57 of the groove 34 located along the horizontal upper surface 67 of the stiffener ring 25 and the horizontal lower surface 65 of the groove located along the horizontal lower surface 66 of the stiffener ring, the retainer ring is securely locked to the stiffener ring.
With the inwardly facing annular region 34 of the retainer ring thus engaged about the outer surface 28 of the stiffener ring, the retainer ring is secured to the orifice ring with the fabric member interposed and firmly held between the retainer ring and the stiffened orifice ring. During application of the retainer ring to the orifice ring-stiffener ring assembly, any slack in the inner portion of t~e fabric member is taken up so the fabric, which surrounds the retainer ring, now fully covers the surfaces of the protruding portion of the stiffener ring.
Illustrated in FIGURE 6 is an alternative embodiment of a heart valve 111 and a surrounding a suture ring 113 particularly adapted for insertion in an aortic location~ Although the heart valve 111 and suture ring 113 will in use be orientated in accordance with anatomy of the heart, for ease of description, the heart valve and suture ring are described as havinq an upper and a lower end, with reference to FIGURES 6-10.
The illustrated heart valve 111 has a single disc occluder 115 mounted within an orifice ring or valve body 117 for pivoting hetween an open position to allow blood ~low through a central passageway 119 and a closed position to block blood flow through the passageway. In the illustrated heart valve 111, the valve body 117 is stiffened by being formed with an integral encircling protrusion 121. Because of the stiffness provided by the integral protrusion, it may be aesirable to form the occluder 115 to be sufficiently resiliently deformable to permit its insertion into the valve body 117, or the occluder and/or mounting means may be fabricated to permit mounting of the occluder in a substantially non-deformable valve body~ It i5 to be understood that the aortic suture ring 113 is equally suitahle for use with a heart valve such as that illustrated with reference to FIGURES 1-5, haviny a stiffener ring in interference it in a peripheral groove of the heart valve body.
Physiological differences between the mitral and aortic locations require some desiyn differences between suture rings used in mitral locations and suture rings in aortic locations. The mitral valves extend between two heart chambers, and when a defective natural mitral valve i8 removed, a broad surface is provided along the entrance ~o the opening. Thus, a broad suture flange, such as that in the embodiment of FIGURES 1-5, is preferably attached thereto. In the aortic location, however, the suture ring must be sutured to the walls of the passageway, and such a broad suturing flange is not appropriate for an aortic valve suturing ring.
Furthermore, although a fabric ~ube 123 in the aortic ring fully covers the surfaces of a retainer ring 1259 the fabric tube 123 is preferably not interposed between the valve body protrusion 121 and the retainer ring in order to further minimize the thickness of the valve body-suture ring assembly, but rather, the fabric tube is secured between the valve body 117 and retainer ring 125 at locations both above and below protrusion 121.
The retainer ring 125 is fabricated as a unitary, generally tubular piece of metal. The main body is a narrow central annulus 127 having an interior surface 129 proportioned to fit closely about the outer surface 131 of the encircling protrusion 121 and an annular flange 135, that extends inward of the annulus 127 and lies adjacent the upper surface 137 of the protrusion 121. A thin tubular section 139 extends a substantial distance upward from the body and is deformed inward in the assembled unit. Because it is not intended to greatly deform this section/ there should be no need to provide slots to accommodate deformation without buckling, and in the ill~strated embodiment~ none are provided.
t A lower thin tubular section or portion 141 extends a substantial distance downward from the main body, and because this tubular section is deformed substantially during its application to the value body, a plurality of slots 143 (FIGURE 7) are formed extending upward into this lower tubular section creating a plurality of individually deformable tangs 145 The lower end of the tubular portion 141 is formed with a rib that extends inward to provide each tang with an inward protuberance 147. Although the tangs 145 in the aortic suture ring resemble the tangs in the herein before-described mitral suture ring, each having an inward protuberance, the tangs of the aortic suture ring are crimped into engagement about the valve body protrusion 121, rather than being snap-fit onto the protrusion, as is the case in the mitral valve suture ring. Thus, the protuberances 147 do not extend . sufficiently inward to lie below the protrusion until they are irreversably deformed by crimping. The narrow, horizontal upper surfaces 149 of the tang protuberances 147 provide secure locking when the tangs are crimped to lock ~he retainer ring 125 to the valve body. The interior surface 129 of the main body does not extend the full distance along the valve body protrusion 121 permitting the tangs 145 to be formed of greater length and therefor more easily crimped.
: Although the fabric tube 123 is no~ intended to fully encircle the retainer ring 125 and is not interposed between the interior surface of the annulus and the outer surface of the protrusion, the ~ength of the fabric tube is preferably substantially longer than the height of the retainer ring to provide a double layer of material along the exterior of the retainer : ring to be sutured to the heart tissues and to also provide portions that envelop the upper and lower ends , and are tucked between the retainer ring and the valve ., ,.i body and held therein by means of dam rings or bands 151, 153. The fabric tube is preferably precreased for fitting around ~he ends of the retainer ring and looping around upper and lower fabric-holding bands 151, 153.
The fabric-holding bands 151~153 s~cure the ends of the abric tube to the retainer ring to fully cover those portions of the retainer ring that would otherwise remain exposed after the retainer ring is locked to the valve body, and they are formed of rigid metal. Rigid metal bands are preferable to tied cords ~: for securing fabric ends between two generally rigid members, i.e., ~he valve body 117 and the retainer ring , 125, and facilitate assembly.
; The illustrated bands 151, 1S3 have rectangular cross sections being cut from cylindrical tubes;
however, bands having round cross sections or other configurations could be used. The bands typically have cross-sectional dimensions of about 0.7 mm in the axial direction by 0.5 mm in the radial direction for a rigid metal; such as titanium.
~' The upper band 151 is proportioned for - insertion between the upper tubular segment 139 of the ,- retainer ring 125 and the heart valve body 117 above the protrusion 121 leaving sufficient clearance around the band for a looped portion of the fabric tube 123 to surround the ring. The outside diameter of the upper ring is closely matched to the interior diameter of the ; upper tubular segment 139 whereby the fabric is captured between the band 151 and the tubular segment, and a slight amount of inward crimping of the upper tubular segment is sufficient to retain the upper band 151 in its installed position on the retainer ring. Insertion of the fabric-surrounded upper band 151 and inward crimping of the upper tubular segment 139 is generally completed before the retainer ring is applied to the - valve body, the upper tubular segment serving no ;
' .
;,' ~ . .
~l2~
function in locking the retainer ring 1~5 to the valve body, The lowef band 153 is proportioned to be received between the tangs 145 and the valve body 117 as 5 shown in FIG~ 9, where it can be seen that the outside diameter of the lower band 153 is significantly less than the uncrimped interior diameter of the ring of tangs 145. In locking ~he retainer ring 125 to the valve body, the tangs are crimped a substantial distance 10 inward serving the dual functions of pinning the lower end of the fabric tube between the band 153 and the lower surface 155 of the protrusion 121 and holding the ;. lower band 153 in permanen~ position be~ween the : retainer ring and the protrusion to lock the retainer c 15 ring to the valve body.
To assemble the suture ring 113, the retainer ring 12S is placed on a jig (not shown), and the fabric tube 123 is extended through the central passageway of the retainer ring with that portion of the fabric tube 20 which is to serve as an inner fabric layer 152 at the upper end. The upper band 151 is then inserted into retainer ring along the inside of the upper tubular - segment 139 and inside of the fabric tube 123 and pushed ~ downward to hold the fabric tube against the inwardly 25 extending flange 135. Thereupon, a die is used ~o crimp the upper tubular segment 139 radially inward until its upper edge overhangs the upper band 151, locking the ; upper band in place and firmly pinning the fabric tube between the upper band and the upper tubular segment 139 30 and flange 135. With the fabric tube pinned in place, the upper portion 152 of the fabric tube 123 above the ring is folded over the upper edge of the upper tubular segment 139 and downward along the outside of the retainer ring, extending almost to its lower end. Next, 35 the remaining portion 154 of the fabric tube 123 is pulled up through the central passageway of the retainer `:
"
ring and likewise folded over t~e top and ~long the outside of the retainer ring overlying the inner layer 152 of the fabric tube. At this stage, the partially prepared suture ring (FIG. 8) is ready for application to a heart valve body 117 having a surrounding protrusion 121, and the retainer ring 125 is removed from the jig.
The valve body 117 and partially prepared retainer ring 125 are then mated (as shown in FIG. 8).
The retainer ring 125 is inverted and inserted into another jig (not shown). The valve body 117 is inserted into the retainer ring 125 so that the body protrusion 121 seats on the suture ring flange 135 with the outer surface of the protrusion 131 fitting closely along the interior surface 129 of the central annulus 127. That portion of the fabric tube 123 that extends helow the tangs is folded inward, and the lower band 153 i5 pushed downward into the annular region between the inverted valve body 117 and the tangs 143 until it seats against the protrusion 121, carrying the surrounding fabric inward 80 that a loop 159 o~ fabric is pinned between the band and the valve body 117. Finally, the tangs 145 are crimped inward to lock the suture ring to the valve body by pressing them against the lower band 153 ana the fabric tube loop 159 to force them against the protrusion. Any excess fabric tube that extends outward beyond the end of the valve body and retainer ring is trimmed away. The fabric may also be coated with vapor-deposited carbonO
Several advantages of the heart valves should now be more fully appreciated. The suture rings are fully assembled with the heart valves prior to their insertion into a heart where they are implanted by suturing. The protrusions, whether they are inte~ral with the valve bodies or are separate stiffener rings, provide rigidity to otherwise thin, somewhat flexible, ~z~
valve bodies eliminating the possibility that the valve members may be released from the valve bodies during surgical implantation into the heart. The outer fabric coverings have no exposed seams, through which blood S might seep or ~-hich might be pulled loose, nor any exposed ends. The simple assembly of the retainer rings and the convenient means for locking the retainer rings onto the valve bodies substantially reduce the assembly time, which represents a significan~ portion of present heart valve manufacturing costs, The invention has been described in terms of certain preferred embodiments however, modifications obvious to one with ordinary skill in the art may be made without departing from the scope of the invention.
Various features of the invention are set forth in the following claimsO
SUTURE RINGS FOR HEART VALVES
The present invention relates to heart valve prostheses and more particularly to improved suture rings for implantin~ heart valves.
~
Artificial heart valves for suryical implantation in the human heart are check valves which permit blood flow through the valves in a downstream direction but block regurgitation of olood in a reverse or upstream direction. In spite of the rela~ively simple concept of a check valve, much effort has been exerted in improving the design of heart valves which are implanted into the human heart and should desirably function reliahly for a lifetime.
Heart valves having pivoting valve members, either in the form of a single occluder, such as described in U.S. Patent No. 4,123,805, or a pair of leaflets, such as described in U.S. Patent No.
4,254,50~, provide yood flow characteristics and quick response to blood flow. As a means for inserting heart valves into the hear~, they commonly have attached fabric members suturable to the tissues of ~he heart.
Frequently the fabric member is attached to a separate suture ring which is applied to the periphery of the hear~ valve body or orifice ring, for example, as described in U~S. Paten~ No~ 3,763,548. An important design consideration for heart valves and their suture rings is minimizing their thickness in a radial ; direction in order to maximize the size of the blood flow passageway of the heart valve that is inserted in a natural passageway of a given size. Newer, thinner heart valve bodies formed, for example, as unitary structures of pyrolytic carbon have enabled larger valve passageways to be provided; however, thin heart valve bodies sometimes lack the rigidity that is desirable for such valves.
. \", '~'~
,. \
In some cases, deformability of the heart valve body is advantageous as where the occluder and valve body have cooperating depressions and protruslons and the resiliently deformable valve body is deformed to permit insertion of the occluder and ~he resilient valve body is allowed ~o spring back into engagement with the occluder. In other instances, engayement of the occluder with the valve body may be accomplished by deformation of the occluder or by other means. In any case, deformability of the valve body is undesirable in an assembled heart valve. ~lthough after insertion into the heart, the valve is not subjected to substantial deforming Eorces, the possibility remains that a surgeon could inadvertantly deform the orifice ring and dislocate the occluder as he is inserting the valve into the heart. The heart valve body in combination with the suture ring should therefore provide sufficient - resistance to deformation that there is no danger of displacing the occluder during insertion into the heart.
The need continues for improved suture rings which together with the heart valve bodies occupy a narrow region along the heart passageway and which toge~her provide the rigidity needed to assure that ~he ; valve body will not be deformed during insertion. The fabric member portion of the suture ring should be continuous, fully covering any exposed metal portions of a suture ring, and exposed seams and fabric ends are to be avoided.
SUMMARY OF THE INVENTION
; 3~ Sutue rings, having fabric coverings for suturing to the heart tissues~ are provided that lock onto protrusions which surround orifice rings of heart valves adding stiffness thereto. The suture rings have inner surfaces which overlie outer surfaces of the protrusion, first end portions which engage one end surface of the protrusion and second end portions which . ~
are deformable to engage the opposite end surfaces of the protrusions. The fabric coverings are secured to the retainer rings with bands, and deformable sections of the retainer ring permanently position the banas in place along the retainer ring.
In a specific embodiment, the protrusion on which the retainer ring is locked is an outwardly extending portion of a stiffener ring received in interference fit in a peripheral groove of the orifice ring.
Brief Description of the Drawi_~
FIGURE 1 is a perspective view of a bileaflet heart valve and a suture ring assembly, embodying various features of ~he invention, for insertion in a mitral location;
FIGURE 2 is an exploded perspective view of the suture ring assembly;
FIGURE 3 is an enlarged cross-sectional view of the suture ring of FIGURE 2 in a condition nearly ready for mating with the heart valve;
FIGURE 4 is an enlarged frag~entary cross-sectional view similar to FIGURE 3 illustrating mating of the assembly with the heart valve;
FIGURE 5 is an enlarged cross-sectional view taken generally along line 5-5 of FIGURE l;
FIGURE 6 is a perspective view of a heart valve having a single disc occluder and an alternative embodiment of a suture ring assembly, embodying various features of the invention, for insertion in an aortic location;
FIGURE 7 is an exploded perspective view of the suture ring assembly and heart valve body of FIGURE 6;
FIGURE 8 is an enlarged cross-sectional view of the suture ring of FIGURE 6 preparatory to mating with the heart valve body;
~4--FIGURE 9 is an enlarged fraymentary cros~-sectional view, similar to FIGURE 8, showing the valve body slipped into the prepared suture ring of FIGURE 8; and FIGURE 10 is an enlarged cross-sectional view taken along line 10-10 of FIGURE 6.
Detailefl Description of the Preferred Embodiment Illustrated in FIGURE 1 is a heart valve 11 which carries a suture ring assembly 13 particularly adapted for insertion in a mitral location. The suture ring assembly has an outer covering 15 of porous fabric which can be sutured to the tissue of the heart and to which the fibrous tissues of the heart will attach during healing.
The illustrated hear~ valve 11 has two leaflets or valve members, such as described in the above-mentioned '508 Patent in which a pair of generally semi-circular leaflets 17 are mounted within an orifice ;~ ring or valve body 19 for pivoting between an open ,! 20 position to allow blood flow through the orifice or ~` passageway and a closed position to block blood flow.
The leaflets 17 are mounted in the orifice ring by I suitable interengagement means (not shown) which may `~ include depressions and/or protuberances on the interior of the orifice ring and cooperating depressions and/or protuberances at the periphery of each leaflet 7 which interengagement means forms no part of the present ~: invention.
Such orifice rinqs are often formed of materials that are somewhat resiliently deformable in order to be deformed for insertion of the valve members 17. When the orifice ring 19 returns to its annular configuration, the depressions and/or protrusions of the orifice ring and valve members 17 mount the valve - 35 members for pivotal motion. ~ particularly suitable , material for formation of valve members and orifice :;' ., z~
rings is pyrocarbon, such as that sold under the trademark PYROLITE, which has a surface with highly thromboresistant characteristics. Orifice rings formed of pyrocarbon or of materials such as graphite coated with pyrocarbon may be deformed sufEiciently for mounting of the valve members.
Heart valves 11 generally have orifice rings 19 with shallow outwardly facing annular yrooves 23. In accordance with one aspect of the present invention, the suture ring assembly 13 includes an inner stiffener ring 25, which interfits with the annular groove and stiffens the orifice ring against deforma~ion during surgical implantation, an outer surrounding retainer ring 33 and a fabric member 31 which is suturable to the tissues of the heart. An inner surface 27 of the stiffener ring 25 is held in interference fit within the shallow annular groove 23, and the thickness of the ring is such that its outer surface 29 extends radially outward of the outer surface of the orifice ring. The retainer ring 33 has an interior region or groove 34 which accommodates the outwardly protruding portion 28 o the stiffener ring 25 with a fabric member 31 interposed and held therebetween.
The fabric member 31, which is initially tubular in shape, is wrapped into a closed loop configuration around the retainer ring 33 with its ends 35a, 35b joined together to form the cover 15 which fully surrounds the retainer ring, and the junction between the overlapping ends 35 of the tubular fabric member is locked into a non-exposed position~ Enclosure of the junction is achieved by a deformable section comprised of a ring of tines 41 that extend from a rigid annulus 43 of the retainer ring and are crimped into a curved configuration around the junction.
Generally, the application of the suture ring assembly 13 to the heart valve is as follows. The stiffener ring 25, which is formed of metal, is shrink-Eitted into an interference fit within the outwardly facing groove 23 by first heating it to expand its diameter. The fabric member 31 is wrapped into its closed loop configuration around the retainer ring 33 and its ends are joined with a pair of cords or ties, one tie 37a banded around a first end 35a and a second tie 37b banded around the second end 35b~ The ring of tines 41, which have been partially pre-crimped outward (as shown in FIG. 3), are further crimped toward the annulus 43 to lock in the ties and surrounding fabric.
The fabric covered retainer ring 33, is thereafter snapped onto the stiffener ring 25 by means of a deformable segment consisting of a ring of resilient prongs or tangs 45 that ex~end from the annulus 43 in the opposite direction from the tines 41.
So that the invention may be more fully understood, the suture ring assembly will now be described in greater detail. Although it is understood that ~he heart valve and suture ring assembly will be oriented within the heart valve in the orientation of the replaced natural heart valve, for ease of explanation, the vertical orientation of the several members will be described with reference to FIGURES 1 5 of the drawings.
The stiffener ring 25 is of annular shape ; having a generally rectangular cross section; however, the upPer outer edge 47 is chamfered to facilitate application of the retainer ring 33 as described hereinbelow. The inner surface 27 of the stiffener ring is generally matched to the shape of the shallow groove 23 of the orifice ring 19 with the inside diameter of the stiffener ring substantially equal to the root diameter of the groove and the height of the ~tiffener ring substantially equal to that of the groove. The thickness o~ the stiffener ring is greater than the r depth of the groove so that the outer surface 28 of the ring protrudes radially outward of the orifice ring 19.
As a means of fitting the stiffener ring 25 over one end of the orifice ring 19 and into the groove 23, the stiffener ring is first heated to high temperatures until it expands sufficiently to slide over the ring. The heat-expanded stiffener ring is positioned around the groove and cooled to ambient temperatures whereat it seats snugly in the groove~ The metal of which the stiffener ring is formed has a coefficient of ~hermal expansion sufficient to permit i~s application, when hea~ed, to the orifice ring.
Although the stiffener ring in the final assembly is shielded by the fabric covering 15 from contac~ with blood or tissue, the metal used to form the stiffener ring is selected for biocompatibility and thromboresistance. A Co-Cr alloy is a preferred material for formation of the stiffener ring which may ; be heated to about 900F for application to the orifice ring.
The retainer ring 33 is fabricated as a ; unitary, generally tubular piece of metal appropriately ~ slit to provide the rings of tines 41 and tangs 45 - extending in opposite directions from the central annulus 43. Although the retainer ring is fully covered with fabric in the complete heart valve-s~iffener ring-retainer ring assembly, the metal is also selected for biocompatibility and ~hromboresistanceO The central portion of the metal retainer ring has a thickness sufficient that it will not deform under the conditions of suture ring assembly. The tangs 45 are less thick and in the process of suture ring assembly will deflect~
but the "memory~ of the resilient metal returns the tangs to their original configuration. The tines 41 are relatively thin and are deformed past their elastic limit and during suture ring assembly assume the shape 5~
into which they are deformed. A preferred ~etal for fabrication of the retainer ring is titanium. Other metals, such as stainless steel, may also be used to ~ fabricate ~he retainer ring, or a material having similar deformable properties might be used instead of metal.
The central annulus 43 is relatively thick giving shape and rigidity to the retainer ring 33. The inner surface 51 of the annulus has a diameter slightly greater than the outer diameter of the orifice ring to accommodate a layer of fabric therebetween.
Below the central annulus 43, the inwardly facing annular groove or region 34 is formed to accommodate the outwardly protruding portion 28 of the ' 15 stiffener ring 25 leaving a lower annular ri~ 44. The groove 34 is proportioned to accommodate a ~ingle layer , of the tubular fabric member 31 interposed between the stiffener ring and the retainer ring along an upper surface or overhang 57, a vertical surface 59 and a lower surface 65 of the groove.
To facilitate interconnection of the retainer ring and the orifice ring-stiffener ring assembly, the retainer ring 33 is divided by a plurality of slits 55 into the ring of resilient tangs 45 extending downward from the central annulus 43. The lower rim 44 is divided by the slits S5 into radially inwardly extending . lugs Sl at the ends o the tangs 45. Preferably, the ;; under~urfaces 63 of the lugs 61 are rounded to ` facilitate camming of the lugs over the upper surface 64 and the outer surface 29 of the stiffener ring 25 during mating of the retainer ring to ~he orifice ring-stiffener ring assemblyO ~etween the lugs 61 and the annulus~ the thickness of the tangs 45 is such to allow them to deform outwardly during retainer ring application and snap back thereaFter to surround and engage the stiffener ring.
":;
, .
..Z~
Above the annulus 43, a thin tubular portlon 67 of the retainer ring 33 is divided by a plurality of slits 68 into the ring of tines 41~ The thin tine~ are deormed past their elastic limit upon the applicatlon of sufficient crimping force thereto. The tines 41 are precrimped prior to application of the fabric member, using suitable dies, into the outwardly curved configuration seen in FIGURE 3, and the precrimped tines, along with an outwardly extending flange 71 of the annulus 43, provide an outwardly facing annular region 79.
The fabric member 31 is formed of fabric selected for lifetime durability as well as compatibility with blood and heart tissue. A woven or knitted fabric provides porosity for ingrowth of ~eart tissue, and a preferred material for the fabric member is Dacron knit fabric. The length of the tubular fabric member is sufficient to fully surround the retainer ring closely following its contours as well as providing a radially extending flap 75 for suturing to the heart tissue.
To facilitate handling and suturing, it is preferred that the flap 75 be thickened, and this is preferably ~ccomplished by means of a resilient polymeric filler ring 76, e.g., formed of low density or foanl polytetrafluoroethylene, such as that sold under the trademark Teflon. The filler ring has a semi-elliptical cross section, its inner surface 78 being substantially vertical and having a diameter match2d to the outside diameter of the finally crimped tines 41 as seen in FIG. 5. ~he Teflon Eiller rinq 76 is easily penetrated by suturing needles. Alternatively, the flap could be thickened using a longer fabric member 31 and folding and layering its ends, but the close knit oE the fabric makes it difficult for suturing nee-lles to penetrate multiple layers~
.~.
-h~
The tubular fabric member 31 is wrapped around the re~ainer ring 33 prior to its appllcation to the orifice ring 19 and fitted stiffener ring 25. The fabric member 31 is shown in FIGURE 2 in its simple tubular configuration; however, prior to applicatioll to the retainer ring, the fabric member is preferably pre-creased, e.g., by steam pressing, in order to closely conform to the shape of the retainer ring which it is to cover. Various dies are used in pre~creasing the fabric member to conform to the contours of the retainer ring. The fabric is creased to follow the contours of inwardly facing annular region 34. On the outside of the retainer ring, a segment of the fabric stretches from the undersurface 63 of the lugs to the upper surface of the central portion of the retainer ring 33.
Within the outwardly facing annular region 79 provided by the precrimped tines 41, the first or lower end 35a of the fabric member is securely tied with one of the suture cords 37a leaving a short length 81 of the first end extending beyond the point of tying. The outwardly curved tines prevent upward displacement of the tightly tied cord. The filler ring 76 is t'nen placed around the ring of precrimped tynes 41, its inner surface 78 being deformed by the tines which have not yet been fully crimped, as seen in FIG. 3. The second or upper end of the fabric member 31 is brought arounA
the filler ring 76, tucked below the tines 41 and tied tightly with the second cord 37b within the annular region 79. The second end overlaps the first end completing the closed loop configuration of the fabric covering 15. The free terminus 83 o the second end extending beyond the tie is folded back upon itself into the region radially exterior of the two ties so it lies along the free length 81 o the first end leaving no ` exposed fabric ends to fray or interfere with the flow .
of blood. In order that the second cord may be knotted, its ends may be threaded through the fa~ric and tied exterior of the closed fabric loop. The cords maintain the fabric in position along the retainer ring and filler ring 76. The tines 41 are then crimped to their final configuration so they extend substantially back to the flange 71 of the annulus 43, locking the cords 37 and fabric end portions in the annular region 79 ~etween the crimped tines and the flange.
The loose multilayered flap 75 of the fabric member is steam-pressed for the final time in~o a flat annular configuration extending radially outward of the upper end of the retainer ring for suturing to the heart tissues and in particular to the tissue at the interior of a passageway remaining after excision of a natural mitral valve. The fabric-covered suture ring at this stage may be coated with vapor-deposited carbon, 5uch as that sold under the trademark Biolite, giving the exposed fabric a highly thromboresistant surface.
The covered, coated retainer ring i5 ready for application to the heart valve-stiffener ring assembly.
The retainer ring is pressed downward over the orifice ring-stiffener ring assembly as seen in FIGURE 4. When the lower curved surfaces 63 of the tang lugs 61 contact the chamfered upper edge 47 of the stiffener ring, the tangs 45 resiliently deform outwardly, and when the flat upper surfaces 65 of the lugs reach the bottom edge of the stiffener ring, the tangs spring ~ack inward locking the retainer ring in surrounding relationship about the stiffener ring. With the horizontal upper surface 57 of the groove 34 located along the horizontal upper surface 67 of the stiffener ring 25 and the horizontal lower surface 65 of the groove located along the horizontal lower surface 66 of the stiffener ring, the retainer ring is securely locked to the stiffener ring.
With the inwardly facing annular region 34 of the retainer ring thus engaged about the outer surface 28 of the stiffener ring, the retainer ring is secured to the orifice ring with the fabric member interposed and firmly held between the retainer ring and the stiffened orifice ring. During application of the retainer ring to the orifice ring-stiffener ring assembly, any slack in the inner portion of t~e fabric member is taken up so the fabric, which surrounds the retainer ring, now fully covers the surfaces of the protruding portion of the stiffener ring.
Illustrated in FIGURE 6 is an alternative embodiment of a heart valve 111 and a surrounding a suture ring 113 particularly adapted for insertion in an aortic location~ Although the heart valve 111 and suture ring 113 will in use be orientated in accordance with anatomy of the heart, for ease of description, the heart valve and suture ring are described as havinq an upper and a lower end, with reference to FIGURES 6-10.
The illustrated heart valve 111 has a single disc occluder 115 mounted within an orifice ring or valve body 117 for pivoting hetween an open position to allow blood ~low through a central passageway 119 and a closed position to block blood flow through the passageway. In the illustrated heart valve 111, the valve body 117 is stiffened by being formed with an integral encircling protrusion 121. Because of the stiffness provided by the integral protrusion, it may be aesirable to form the occluder 115 to be sufficiently resiliently deformable to permit its insertion into the valve body 117, or the occluder and/or mounting means may be fabricated to permit mounting of the occluder in a substantially non-deformable valve body~ It i5 to be understood that the aortic suture ring 113 is equally suitahle for use with a heart valve such as that illustrated with reference to FIGURES 1-5, haviny a stiffener ring in interference it in a peripheral groove of the heart valve body.
Physiological differences between the mitral and aortic locations require some desiyn differences between suture rings used in mitral locations and suture rings in aortic locations. The mitral valves extend between two heart chambers, and when a defective natural mitral valve i8 removed, a broad surface is provided along the entrance ~o the opening. Thus, a broad suture flange, such as that in the embodiment of FIGURES 1-5, is preferably attached thereto. In the aortic location, however, the suture ring must be sutured to the walls of the passageway, and such a broad suturing flange is not appropriate for an aortic valve suturing ring.
Furthermore, although a fabric ~ube 123 in the aortic ring fully covers the surfaces of a retainer ring 1259 the fabric tube 123 is preferably not interposed between the valve body protrusion 121 and the retainer ring in order to further minimize the thickness of the valve body-suture ring assembly, but rather, the fabric tube is secured between the valve body 117 and retainer ring 125 at locations both above and below protrusion 121.
The retainer ring 125 is fabricated as a unitary, generally tubular piece of metal. The main body is a narrow central annulus 127 having an interior surface 129 proportioned to fit closely about the outer surface 131 of the encircling protrusion 121 and an annular flange 135, that extends inward of the annulus 127 and lies adjacent the upper surface 137 of the protrusion 121. A thin tubular section 139 extends a substantial distance upward from the body and is deformed inward in the assembled unit. Because it is not intended to greatly deform this section/ there should be no need to provide slots to accommodate deformation without buckling, and in the ill~strated embodiment~ none are provided.
t A lower thin tubular section or portion 141 extends a substantial distance downward from the main body, and because this tubular section is deformed substantially during its application to the value body, a plurality of slots 143 (FIGURE 7) are formed extending upward into this lower tubular section creating a plurality of individually deformable tangs 145 The lower end of the tubular portion 141 is formed with a rib that extends inward to provide each tang with an inward protuberance 147. Although the tangs 145 in the aortic suture ring resemble the tangs in the herein before-described mitral suture ring, each having an inward protuberance, the tangs of the aortic suture ring are crimped into engagement about the valve body protrusion 121, rather than being snap-fit onto the protrusion, as is the case in the mitral valve suture ring. Thus, the protuberances 147 do not extend . sufficiently inward to lie below the protrusion until they are irreversably deformed by crimping. The narrow, horizontal upper surfaces 149 of the tang protuberances 147 provide secure locking when the tangs are crimped to lock ~he retainer ring 125 to the valve body. The interior surface 129 of the main body does not extend the full distance along the valve body protrusion 121 permitting the tangs 145 to be formed of greater length and therefor more easily crimped.
: Although the fabric tube 123 is no~ intended to fully encircle the retainer ring 125 and is not interposed between the interior surface of the annulus and the outer surface of the protrusion, the ~ength of the fabric tube is preferably substantially longer than the height of the retainer ring to provide a double layer of material along the exterior of the retainer : ring to be sutured to the heart tissues and to also provide portions that envelop the upper and lower ends , and are tucked between the retainer ring and the valve ., ,.i body and held therein by means of dam rings or bands 151, 153. The fabric tube is preferably precreased for fitting around ~he ends of the retainer ring and looping around upper and lower fabric-holding bands 151, 153.
The fabric-holding bands 151~153 s~cure the ends of the abric tube to the retainer ring to fully cover those portions of the retainer ring that would otherwise remain exposed after the retainer ring is locked to the valve body, and they are formed of rigid metal. Rigid metal bands are preferable to tied cords ~: for securing fabric ends between two generally rigid members, i.e., ~he valve body 117 and the retainer ring , 125, and facilitate assembly.
; The illustrated bands 151, 1S3 have rectangular cross sections being cut from cylindrical tubes;
however, bands having round cross sections or other configurations could be used. The bands typically have cross-sectional dimensions of about 0.7 mm in the axial direction by 0.5 mm in the radial direction for a rigid metal; such as titanium.
~' The upper band 151 is proportioned for - insertion between the upper tubular segment 139 of the ,- retainer ring 125 and the heart valve body 117 above the protrusion 121 leaving sufficient clearance around the band for a looped portion of the fabric tube 123 to surround the ring. The outside diameter of the upper ring is closely matched to the interior diameter of the ; upper tubular segment 139 whereby the fabric is captured between the band 151 and the tubular segment, and a slight amount of inward crimping of the upper tubular segment is sufficient to retain the upper band 151 in its installed position on the retainer ring. Insertion of the fabric-surrounded upper band 151 and inward crimping of the upper tubular segment 139 is generally completed before the retainer ring is applied to the - valve body, the upper tubular segment serving no ;
' .
;,' ~ . .
~l2~
function in locking the retainer ring 1~5 to the valve body, The lowef band 153 is proportioned to be received between the tangs 145 and the valve body 117 as 5 shown in FIG~ 9, where it can be seen that the outside diameter of the lower band 153 is significantly less than the uncrimped interior diameter of the ring of tangs 145. In locking ~he retainer ring 125 to the valve body, the tangs are crimped a substantial distance 10 inward serving the dual functions of pinning the lower end of the fabric tube between the band 153 and the lower surface 155 of the protrusion 121 and holding the ;. lower band 153 in permanen~ position be~ween the : retainer ring and the protrusion to lock the retainer c 15 ring to the valve body.
To assemble the suture ring 113, the retainer ring 12S is placed on a jig (not shown), and the fabric tube 123 is extended through the central passageway of the retainer ring with that portion of the fabric tube 20 which is to serve as an inner fabric layer 152 at the upper end. The upper band 151 is then inserted into retainer ring along the inside of the upper tubular - segment 139 and inside of the fabric tube 123 and pushed ~ downward to hold the fabric tube against the inwardly 25 extending flange 135. Thereupon, a die is used ~o crimp the upper tubular segment 139 radially inward until its upper edge overhangs the upper band 151, locking the ; upper band in place and firmly pinning the fabric tube between the upper band and the upper tubular segment 139 30 and flange 135. With the fabric tube pinned in place, the upper portion 152 of the fabric tube 123 above the ring is folded over the upper edge of the upper tubular segment 139 and downward along the outside of the retainer ring, extending almost to its lower end. Next, 35 the remaining portion 154 of the fabric tube 123 is pulled up through the central passageway of the retainer `:
"
ring and likewise folded over t~e top and ~long the outside of the retainer ring overlying the inner layer 152 of the fabric tube. At this stage, the partially prepared suture ring (FIG. 8) is ready for application to a heart valve body 117 having a surrounding protrusion 121, and the retainer ring 125 is removed from the jig.
The valve body 117 and partially prepared retainer ring 125 are then mated (as shown in FIG. 8).
The retainer ring 125 is inverted and inserted into another jig (not shown). The valve body 117 is inserted into the retainer ring 125 so that the body protrusion 121 seats on the suture ring flange 135 with the outer surface of the protrusion 131 fitting closely along the interior surface 129 of the central annulus 127. That portion of the fabric tube 123 that extends helow the tangs is folded inward, and the lower band 153 i5 pushed downward into the annular region between the inverted valve body 117 and the tangs 143 until it seats against the protrusion 121, carrying the surrounding fabric inward 80 that a loop 159 o~ fabric is pinned between the band and the valve body 117. Finally, the tangs 145 are crimped inward to lock the suture ring to the valve body by pressing them against the lower band 153 ana the fabric tube loop 159 to force them against the protrusion. Any excess fabric tube that extends outward beyond the end of the valve body and retainer ring is trimmed away. The fabric may also be coated with vapor-deposited carbonO
Several advantages of the heart valves should now be more fully appreciated. The suture rings are fully assembled with the heart valves prior to their insertion into a heart where they are implanted by suturing. The protrusions, whether they are inte~ral with the valve bodies or are separate stiffener rings, provide rigidity to otherwise thin, somewhat flexible, ~z~
valve bodies eliminating the possibility that the valve members may be released from the valve bodies during surgical implantation into the heart. The outer fabric coverings have no exposed seams, through which blood S might seep or ~-hich might be pulled loose, nor any exposed ends. The simple assembly of the retainer rings and the convenient means for locking the retainer rings onto the valve bodies substantially reduce the assembly time, which represents a significan~ portion of present heart valve manufacturing costs, The invention has been described in terms of certain preferred embodiments however, modifications obvious to one with ordinary skill in the art may be made without departing from the scope of the invention.
Various features of the invention are set forth in the following claimsO
Claims (20)
1. A suture ring for a heart valve having a valve body providing a blood flow passageway, occluder means mounted within said valve body for opening and closing the passageway and a protrusion around the valve body having first and second end surfaces, the suture ring comprising a retainer ring having an interior surface proportioned to surround said protrusion, inwardly extending means for engaging said first end surface of the protrusion and a deformable end portion for engaging the second end surface to lock said retainer ring onto the protrusion, a fabric tube surrounding said retainer ring, said fabric tube being interposed between said retainer ring and said protrusion, band means for securing the opposite ends of said fabric tube together, and deformable means which forms a part of said retainer ring for holding said band means in permanent position, said deformable means being deformed from a first position adjacent to said band means to a second permanent lock position about said band means.
2. A suture ring in accordance with Claim 1 wherein said deformable means is a ring of tines substantially encircling said band means.
3. A suture ring in accordance with Claim 2 wherein said retainer ring has an outwardly extending flange, and said tines are crimped to extend substantially to said flange.
4. A suture ring according to Claim 1 wherein said deformable end portion of said retainer ring is resiliently deformable so that said retainer ring may be snap-fit about said protrusion, said deformable end portion deforming outwardly as it is forced over said protrusion and thereafter returning inwardly to engage said second end surface of the protrusion.
5. A suture ring according to Claim 1 wherein said deformable end portion of said retainer ring comprises a ring of deformable tangs.
6. A suture ring for a heart valve having a valve body providing a blood flow passageway, occluder means mounted within said valve body for opening and closing the passageway and a protrusion around the valve body having first and second end surfaces, the suture ring comprising a retainer ring having an interior surface proportioned to surround said protrusion, inwardly extending means for engaging said first end surface of the protrusion and a deformable end portion for engaging the second end surface to lock said retainer ring onto the protrusion, a fabric tube, band means for securing the ends of said fabric tube to said retainer ring so that exposed surfaces of said retainer ring when it is locked onto said protrusion are fully covered by said fabric tube, said band means comprising a first band for securing one end of said fabric tube to said retainer ring and a second band for securing the other end of said fabric tube to said retainer ring, and deformable means which forms a part of said retainer ring for holding at least said first band in permanent position.
7. A suture ring according to Claim 6 wherein said deformable means comprises a first deformable retainer ring section for permanently positioning said first band and a second deformable retainer ring section for permanently positioning said second hand.
8. A suture ring according to Claim 6 wherein said deformable end portion provides means for permanently positioning one of said bands.
9. A suture ring according to Claim 8 wherein said deformable end portion holds said one band in permanent position between the retainer ring and the valve body.
10. A suture ring according to Claim 9 wherein said deformable end portion is permanently crimped to permanently position said one band.
11. A suture ring according to Claim 6 wherein said first and second bands are rigid rings.
12. A suture ring according to Claim 6 wherein said second end portion of said retainer ring is resiliently deformable so that said retainer ring may be snap-fit about said protrusion, said second end portion deforming outwardly as it is forced over said protrusion and thereafter returning inwardly to engage said second end surface of the protrusion.
13. A suture ring according to Claim 6 wherein said fabric tube surrounds said retainer ring, said fabric tube being interposed between said retainer ring and said protrusion with said band means holding opposite ends of said fabric tube together.
14. A suture ring in accordance with Claim 13 wherein said retainer ring has tine means substantially encircling said band means.
15. A suture ring in accordance with Claim 14 wherein said retainer ring has an outwardly extending flange, and said tine means are crimped to extend substantially to said flange.
16. A suture ring according to Claim 6 wherein said deformable end portion of said retainer ring comprises a ring of deformable tangs.
17. In combination, a heart valve comprising a valve body providing a blood flow passageway, occluder means mounted within said valve body for opening and closing said passageway, and an annular groove around the valve body;
a stiffener ring in interference fit within said groove, a portion of said stiffener ring extending outward of said groove to provide a protruding portion having first and second end surfaces; and a suture ring comprising a retainer ring having an interior surface proportioned to fit about said protruding portion of said stiffener ring, radially inwardly extending means for engaging said first end surface and a deformable end portion for engaging said second end surface to lock said retaining ring onto said stiffener ring, and a fabric member covering exposed surfaces of said retainer ring.
a stiffener ring in interference fit within said groove, a portion of said stiffener ring extending outward of said groove to provide a protruding portion having first and second end surfaces; and a suture ring comprising a retainer ring having an interior surface proportioned to fit about said protruding portion of said stiffener ring, radially inwardly extending means for engaging said first end surface and a deformable end portion for engaging said second end surface to lock said retaining ring onto said stiffener ring, and a fabric member covering exposed surfaces of said retainer ring.
18. A combination according to Claim 17 wherein said fabric member is tubular and band means secure opposite ends of said tubular fabric member to said retainer ring.
19. A combination according to Claim 18 wherein said retainer ring has a deformable section for holding said band means in association with said retainer ring.
20. A suture ring for a heart valve having a valve body providing a blood flow passageway, occluder means mounted within said valve body for opening and closing the passageway and a protrusion around the valve body having first and second end surfaces, the suture ring comprising a retainer ring having an interior surface proportioned to surround said protrusion, inwardly extending means for engaging said first end surface of the protrusion and a deformable end portion for engaging the second end surface to lock said retainer ring onto the protrusion, a fabric tube surrounding said retainer ring, said fabric tube being interposed between said retainer ring and said protrusion, band means for securing opposite ends of said fabric tube together with said fabric tube fully covering surfaces of said retainer ring, said retainer ring having deformable tine means and an outwardly extending flange, and said tine means being crimped to extend substantially to said flange to substantially encircle said band means.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/458,618 US4535483A (en) | 1983-01-17 | 1983-01-17 | Suture rings for heart valves |
US458,618 | 1983-01-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1211254A true CA1211254A (en) | 1986-09-16 |
Family
ID=23821472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000444640A Expired CA1211254A (en) | 1983-01-17 | 1984-01-04 | Suture rings for heart valves |
Country Status (12)
Country | Link |
---|---|
US (1) | US4535483A (en) |
EP (1) | EP0119357B1 (en) |
JP (1) | JP2608869B2 (en) |
AT (1) | ATE27542T1 (en) |
AU (1) | AU557515B2 (en) |
BR (1) | BR8400148A (en) |
CA (1) | CA1211254A (en) |
DE (1) | DE3371862D1 (en) |
DK (1) | DK17584A (en) |
ES (1) | ES8601675A1 (en) |
IN (1) | IN159219B (en) |
NO (1) | NO834641L (en) |
Families Citing this family (340)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5387247A (en) * | 1983-10-25 | 1995-02-07 | Sorin Biomedia S.P.A. | Prosthetic device having a biocompatible carbon film thereon and a method of and apparatus for forming such device |
US4759758A (en) * | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US4935030A (en) * | 1985-06-17 | 1990-06-19 | Medtronic, Inc. | Mechanical heart valve prosthesis |
US5084151A (en) * | 1985-11-26 | 1992-01-28 | Sorin Biomedica S.P.A. | Method and apparatus for forming prosthetic device having a biocompatible carbon film thereon |
US4743253A (en) * | 1986-03-04 | 1988-05-10 | Magladry Ross E | Suture rings for heart valves and method of securing same to heart valves |
IL78177A0 (en) * | 1986-03-17 | 1986-07-31 | Yoel Ovil | Prosthetic heart valve and instrument for attaching and/or removing same |
IT1196836B (en) * | 1986-12-12 | 1988-11-25 | Sorin Biomedica Spa | Polymeric or metal alloy prosthesis with biocompatible carbon coating |
GB2206182A (en) * | 1987-05-14 | 1988-12-29 | Dr Dhani Ram Baruah | Mechanical heart valve |
US5032128A (en) * | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
US5290300A (en) | 1989-07-31 | 1994-03-01 | Baxter International Inc. | Flexible suture guide and holder |
IT1240110B (en) * | 1990-02-21 | 1993-11-27 | Sorin Biomedica Spa | CARDIAC VALVE PROSTHESIS |
IT1240111B (en) * | 1990-02-21 | 1993-11-27 | Sorin Biomedica Spa | SUTURE RING FOR CARDIAC VALVE PROSTHESES |
US5035709A (en) * | 1990-03-29 | 1991-07-30 | Baxter International Inc. | Mechanical heart valve with compliant sewing ring |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US5071431A (en) * | 1990-11-07 | 1991-12-10 | Carbomedics, Inc. | Suture rings for heart valves and method of securing suture rings to heart valves |
IT1247037B (en) * | 1991-06-25 | 1994-12-12 | Sante Camilli | ARTIFICIAL VENOUS VALVE |
US5178633A (en) * | 1992-04-21 | 1993-01-12 | Carbon Implants Inc. | Suture ring for heart valve prosthesis |
US5397346A (en) * | 1992-04-28 | 1995-03-14 | Carbomedics, Inc. | Prosthetic heart valve with sewing ring |
US5676651A (en) * | 1992-08-06 | 1997-10-14 | Electric Boat Corporation | Surgically implantable pump arrangement and method for pumping body fluids |
US5397348A (en) * | 1993-12-13 | 1995-03-14 | Carbomedics, Inc. | Mechanical heart valve with compressible stiffening ring |
US6217610B1 (en) | 1994-07-29 | 2001-04-17 | Edwards Lifesciences Corporation | Expandable annuloplasty ring |
US5593435A (en) * | 1994-07-29 | 1997-01-14 | Baxter International Inc. | Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth |
ZA958860B (en) * | 1994-10-21 | 1997-04-18 | St Jude Medical | Rotatable cuff assembly for a heart valve prosthesis |
US6030392A (en) * | 1995-01-18 | 2000-02-29 | Motorola, Inc. | Connector for hollow anatomical structures and methods of use |
US6254618B1 (en) | 1995-01-18 | 2001-07-03 | Pepi Dakov | Connector for hollow anatomical organs |
JPH11507249A (en) * | 1995-03-29 | 1999-06-29 | シーヴィー ダイナミックス.インク.,ドゥーイング ビジネス アズ メディカル インコーポレイテッド | Two leaf heart valve |
US5607470A (en) * | 1995-05-01 | 1997-03-04 | Milo; Simcha | Suture rings for prosthetic heart valves |
US5772694A (en) * | 1995-05-16 | 1998-06-30 | Medical Carbon Research Institute L.L.C. | Prosthetic heart valve with improved blood flow |
ATE310468T1 (en) | 1995-06-07 | 2005-12-15 | St Jude Medical | PROSTHETIC HEART VALVE WITH ENLARGED LUMEN |
US6007577A (en) * | 1995-06-07 | 1999-12-28 | St. Jude Medical, Inc. | Prosthetic heart valve with increased valve lumen |
US6592619B2 (en) | 1996-01-02 | 2003-07-15 | University Of Cincinnati | Heart wall actuation device for the natural heart |
US5957977A (en) * | 1996-01-02 | 1999-09-28 | University Of Cincinnati | Activation device for the natural heart including internal and external support structures |
US6520904B1 (en) | 1996-01-02 | 2003-02-18 | The University Of Cincinnati | Device and method for restructuring heart chamber geometry |
US5788689A (en) * | 1996-01-31 | 1998-08-04 | St. Jude Medical, Inc. | Prosthetic heart valve rotator tool |
US6613085B1 (en) | 1996-01-31 | 2003-09-02 | St. Jude Medical, Inc. | Prosthetic heart valve rotator tool |
US5755783A (en) * | 1996-07-29 | 1998-05-26 | Stobie; Robert | Suture rings for rotatable artificial heart valves |
US5766240A (en) * | 1996-10-28 | 1998-06-16 | Medtronic, Inc. | Rotatable suturing ring for prosthetic heart valve |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US5928281A (en) * | 1997-03-27 | 1999-07-27 | Baxter International Inc. | Tissue heart valves |
US6896687B2 (en) | 1997-05-19 | 2005-05-24 | Pepi Dakov | Connectors for hollow anatomical structures and methods of use |
US6045576A (en) * | 1997-09-16 | 2000-04-04 | Baxter International Inc. | Sewing ring having increased annular coaptation |
US5984959A (en) * | 1997-09-19 | 1999-11-16 | United States Surgical | Heart valve replacement tools and procedures |
US6530952B2 (en) | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US5976183A (en) * | 1998-01-05 | 1999-11-02 | Medical Carbon Research Institute, Llc | Sewing ring for heart valve prosthesis |
US6096074A (en) | 1998-01-27 | 2000-08-01 | United States Surgical | Stapling apparatus and method for heart valve replacement |
US6190408B1 (en) | 1998-03-05 | 2001-02-20 | The University Of Cincinnati | Device and method for restructuring the heart chamber geometry |
US6074418A (en) | 1998-04-20 | 2000-06-13 | St. Jude Medical, Inc. | Driver tool for heart valve prosthesis fasteners |
US6176877B1 (en) * | 1998-04-20 | 2001-01-23 | St. Jude Medical, Inc. | Two piece prosthetic heart valve |
US7722667B1 (en) | 1998-04-20 | 2010-05-25 | St. Jude Medical, Inc. | Two piece bioprosthetic heart valve with matching outer frame and inner valve |
US6024096A (en) * | 1998-05-01 | 2000-02-15 | Correstore Inc | Anterior segment ventricular restoration apparatus and method |
US6250308B1 (en) | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6200341B1 (en) * | 1998-09-25 | 2001-03-13 | Sulzer Carbomedics Inc. | Mechanical heart valve assembly with super-elastic lock wire |
US6358278B1 (en) | 1999-09-24 | 2002-03-19 | St. Jude Medical, Inc. | Heart valve prosthesis with rotatable cuff |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6468305B1 (en) | 2000-05-16 | 2002-10-22 | St. Jude Medical, Inc. | Two piece valve |
US8366769B2 (en) * | 2000-06-01 | 2013-02-05 | Edwards Lifesciences Corporation | Low-profile, pivotable heart valve sewing ring |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US7077861B2 (en) * | 2000-07-06 | 2006-07-18 | Medtentia Ab | Annuloplasty instrument |
US6409758B2 (en) | 2000-07-27 | 2002-06-25 | Edwards Lifesciences Corporation | Heart valve holder for constricting the valve commissures and methods of use |
AU2001285078A1 (en) | 2000-08-18 | 2002-03-04 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
US6730122B1 (en) | 2000-11-28 | 2004-05-04 | St. Jude Medical, Inc. | Prosthetic heart valve with increased lumen |
US6716244B2 (en) * | 2000-12-20 | 2004-04-06 | Carbomedics, Inc. | Sewing cuff assembly for heart valves |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US7935145B2 (en) * | 2001-05-17 | 2011-05-03 | Edwards Lifesciences Corporation | Annuloplasty ring for ischemic mitral valve insuffuciency |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
EP1429690B1 (en) * | 2001-09-26 | 2006-11-29 | Edwards Lifesciences Corporation | Low-profile heart valve sewing ring |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US7201771B2 (en) | 2001-12-27 | 2007-04-10 | Arbor Surgical Technologies, Inc. | Bioprosthetic heart valve |
US6719786B2 (en) * | 2002-03-18 | 2004-04-13 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7118595B2 (en) * | 2002-03-18 | 2006-10-10 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US20030233148A1 (en) * | 2002-04-23 | 2003-12-18 | Ferree Bret A. | Modular components to improve the fit of artificial disc replacements |
US7959674B2 (en) * | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US7081084B2 (en) | 2002-07-16 | 2006-07-25 | University Of Cincinnati | Modular power system and method for a heart wall actuation system for the natural heart |
US7578843B2 (en) * | 2002-07-16 | 2009-08-25 | Medtronic, Inc. | Heart valve prosthesis |
US7850729B2 (en) | 2002-07-18 | 2010-12-14 | The University Of Cincinnati | Deforming jacket for a heart actuation device |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US7399315B2 (en) | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
CH696185A5 (en) * | 2003-03-21 | 2007-02-15 | Afksendiyos Kalangos | Intraparietal reinforcement for aortic valve and reinforced valve has rod inserted in biological tissue or organic prosthesis with strut fixed to one end |
WO2004110257A2 (en) | 2003-06-09 | 2004-12-23 | The University Of Cincinnati | Power system for a heart actuation device |
WO2004110553A1 (en) | 2003-06-09 | 2004-12-23 | The University Of Cincinnati | Actuation mechanisms for a heart actuation device |
US20050010283A1 (en) * | 2003-07-11 | 2005-01-13 | Vedic Biotechnology, Inc. | Heart failure mitral annuloplasty ring with multiple sets of suture placement indicia |
US20050010286A1 (en) * | 2003-07-11 | 2005-01-13 | Vedic Biotechnology, Inc. | Heart failure mitral annuloplasty ring with removable central posterior portion |
US8021421B2 (en) | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US20050075725A1 (en) | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
US7556647B2 (en) | 2003-10-08 | 2009-07-07 | Arbor Surgical Technologies, Inc. | Attachment device and methods of using the same |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
CN100589779C (en) | 2003-12-23 | 2010-02-17 | 萨德拉医学公司 | Repositionable heart valve |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
US20050222675A1 (en) * | 2004-04-06 | 2005-10-06 | Sauter Joseph A | Implantable prosthetic heart valve comprising a valve body and a tubular vascular graft |
AU2004324043A1 (en) | 2004-10-02 | 2006-04-20 | Christoph Hans Huber | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
US7641687B2 (en) * | 2004-11-02 | 2010-01-05 | Carbomedics Inc. | Attachment of a sewing cuff to a heart valve |
US7758640B2 (en) * | 2004-12-16 | 2010-07-20 | Valvexchange Inc. | Cardiovascular valve assembly |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8574257B2 (en) | 2005-02-10 | 2013-11-05 | Edwards Lifesciences Corporation | System, device, and method for providing access in a cardiovascular environment |
US20060195186A1 (en) | 2005-02-28 | 2006-08-31 | Drews Michael J | Connectors for two piece heart valves and methods for implanting such heart valves |
US8083793B2 (en) * | 2005-02-28 | 2011-12-27 | Medtronic, Inc. | Two piece heart valves including multiple lobe valves and methods for implanting them |
US7927369B2 (en) | 2005-03-01 | 2011-04-19 | Leman Cardiovascular Sa | Intraparietal reinforcing device for biological cardiac prosthesis and reinforced biological heart valve prosthesis |
US7575595B2 (en) * | 2005-03-23 | 2009-08-18 | Edwards Lifesciences Corporation | Annuloplasty ring and holder combination |
US7513909B2 (en) | 2005-04-08 | 2009-04-07 | Arbor Surgical Technologies, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
EP2901967B1 (en) | 2005-05-24 | 2019-10-02 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
WO2006127985A2 (en) * | 2005-05-26 | 2006-11-30 | Texas Heart Institute | Surgical system and method for attaching a prosthetic vessel to a hollow structure |
WO2006130505A2 (en) | 2005-05-27 | 2006-12-07 | Arbor Surgical Technologies, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US20090099410A1 (en) * | 2005-06-09 | 2009-04-16 | De Marchena Eduardo | Papillary Muscle Attachment for Left Ventricular Reduction |
US20090082619A1 (en) * | 2005-06-09 | 2009-03-26 | De Marchena Eduardo | Method of treating cardiomyopathy |
US7780723B2 (en) | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US7776084B2 (en) | 2005-07-13 | 2010-08-17 | Edwards Lifesciences Corporation | Prosthetic mitral heart valve having a contoured sewing ring |
CN102113922B (en) | 2005-09-07 | 2013-03-27 | 梅德坦提亚国际有限公司 | A device for improving the function of a heart valve |
US8007530B2 (en) * | 2005-09-30 | 2011-08-30 | Medtronic, Inc. | Tool and method for implanting an annuloplasty prosthesis |
US9011528B2 (en) * | 2005-09-30 | 2015-04-21 | Medtronic, Inc. | Flexible annuloplasty prosthesis |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
EP1988851A2 (en) | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US20070239254A1 (en) * | 2006-04-07 | 2007-10-11 | Chris Chia | System for percutaneous delivery and removal of a prosthetic valve |
US7727276B2 (en) * | 2006-04-14 | 2010-06-01 | Machiraju Venkat R | System and method for heart valve replacement |
WO2007130881A2 (en) | 2006-04-29 | 2007-11-15 | Arbor Surgical Technologies, Inc. | Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them |
US8021161B2 (en) | 2006-05-01 | 2011-09-20 | Edwards Lifesciences Corporation | Simulated heart valve root for training and testing |
US20080004696A1 (en) * | 2006-06-29 | 2008-01-03 | Valvexchange Inc. | Cardiovascular valve assembly with resizable docking station |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
AU2007281553B2 (en) | 2006-07-31 | 2013-09-19 | Edwards Lifesciences Cardiaq Llc | Sealable endovascular implants and methods for their use |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US8236045B2 (en) | 2006-12-22 | 2012-08-07 | Edwards Lifesciences Corporation | Implantable prosthetic valve assembly and method of making the same |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US7815677B2 (en) | 2007-07-09 | 2010-10-19 | Leman Cardiovascular Sa | Reinforcement device for a biological valve and reinforced biological valve |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
DE202008018589U1 (en) | 2007-09-26 | 2016-03-14 | St. Jude Medical, Inc. | Foldable heart valve prostheses |
US9532868B2 (en) | 2007-09-28 | 2017-01-03 | St. Jude Medical, Inc. | Collapsible-expandable prosthetic heart valves with structures for clamping native tissue |
US20090105810A1 (en) | 2007-10-17 | 2009-04-23 | Hancock Jaffe Laboratories | Biological valve for venous valve insufficiency |
EP4079261A1 (en) | 2007-12-14 | 2022-10-26 | Edwards Lifesciences Corporation | Leaflet attachment frame for a prosthetic valve |
US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US9241792B2 (en) | 2008-02-29 | 2016-01-26 | Edwards Lifesciences Corporation | Two-step heart valve implantation |
CA2961051C (en) | 2008-02-29 | 2020-01-14 | Edwards Lifesciences Corporation | Expandable member for deploying a prosthetic device |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US9061119B2 (en) * | 2008-05-09 | 2015-06-23 | Edwards Lifesciences Corporation | Low profile delivery system for transcatheter heart valve |
WO2009149462A2 (en) | 2008-06-06 | 2009-12-10 | Edwards Lifesciences Corporation | Low profile transcatheter heart valve |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
WO2010008548A2 (en) | 2008-07-15 | 2010-01-21 | St. Jude Medical, Inc. | Collapsible and re-expandable prosthetic heart valve cuff designs and complementary technological applications |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
EP2331015A1 (en) * | 2008-09-12 | 2011-06-15 | ValveXchange Inc. | Valve assembly with exchangeable valve member and a tool set for exchanging the valve member |
US8690936B2 (en) | 2008-10-10 | 2014-04-08 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
CN102245256B (en) | 2008-10-10 | 2014-07-23 | 萨德拉医学公司 | Medical devices and delivery systems for delivering medical devices |
US8449625B2 (en) | 2009-10-27 | 2013-05-28 | Edwards Lifesciences Corporation | Methods of measuring heart valve annuluses for valve replacement |
CA2743719C (en) | 2008-11-25 | 2019-03-19 | Edwards Lifesciences Corporation | Apparatus and method for in situ expansion of prosthetic device |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
WO2010090878A2 (en) * | 2009-01-21 | 2010-08-12 | Tendyne Medical, Inc. | Apical papillary muscle attachment for left ventricular reduction |
CA2752899A1 (en) * | 2009-02-18 | 2010-08-26 | Cormatrix Cardiovascular, Inc. | Compositions and methods for preventing cardiac arrhythmia |
US20100217382A1 (en) * | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
WO2011072084A2 (en) | 2009-12-08 | 2011-06-16 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
CN102883684B (en) | 2010-05-10 | 2015-04-08 | 爱德华兹生命科学公司 | Prosthetic heart valve |
US9554901B2 (en) | 2010-05-12 | 2017-01-31 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valve |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
JP5848345B2 (en) | 2010-07-09 | 2016-01-27 | ハイライフ エスエーエス | Transcatheter atrioventricular valve prosthesis |
WO2012012761A2 (en) | 2010-07-23 | 2012-01-26 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
CN106073946B (en) | 2010-09-10 | 2022-01-04 | 西美蒂斯股份公司 | Valve replacement device, delivery device for a valve replacement device and method of producing a valve replacement device |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
CN105380730B (en) | 2010-10-05 | 2018-08-17 | 爱德华兹生命科学公司 | Heart valve prosthesis |
DE202011111128U1 (en) | 2010-10-05 | 2020-05-27 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
AU2012262549B2 (en) | 2011-05-27 | 2016-02-11 | Cormatrix Cardiovascular, Inc. | Extracellular matrix material valve conduit and methods of making thereof |
US9289282B2 (en) | 2011-05-31 | 2016-03-22 | Edwards Lifesciences Corporation | System and method for treating valve insufficiency or vessel dilatation |
CA2835893C (en) | 2011-07-12 | 2019-03-19 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
US9119716B2 (en) | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
EP4289398A3 (en) | 2011-08-11 | 2024-03-13 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
CA3201836A1 (en) | 2011-12-09 | 2013-06-13 | Edwards Lifesciences Corporation | Prosthetic heart valve having improved commissure supports |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
CA2865013C (en) | 2012-02-22 | 2020-12-15 | Syntheon Cardiology, Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US9510946B2 (en) | 2012-09-06 | 2016-12-06 | Edwards Lifesciences Corporation | Heart valve sealing devices |
ES2931210T3 (en) | 2012-11-21 | 2022-12-27 | Edwards Lifesciences Corp | Retention Mechanisms for Prosthetic Heart Valves |
US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9168129B2 (en) | 2013-02-12 | 2015-10-27 | Edwards Lifesciences Corporation | Artificial heart valve with scalloped frame design |
SG11201506352SA (en) | 2013-03-15 | 2015-09-29 | Edwards Lifesciences Corp | Valved aortic conduits |
US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
CA2908342C (en) | 2013-05-20 | 2021-11-30 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
JP6461122B2 (en) | 2013-06-25 | 2019-01-30 | テンダイン ホールディングス,インコーポレイテッド | Thrombus management and structural compliance features of prosthetic heart valves |
EP3027144B1 (en) | 2013-08-01 | 2017-11-08 | Tendyne Holdings, Inc. | Epicardial anchor devices |
SG10202103500PA (en) | 2013-08-12 | 2021-05-28 | Mitral Valve Tech Sarl | Apparatus and methods for implanting a replacement heart valve |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
CN105491978A (en) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
SG11201508895RA (en) | 2013-09-20 | 2015-11-27 | Edwards Lifesciences Corp | Heart valves with increased effective orifice area |
WO2015058039A1 (en) | 2013-10-17 | 2015-04-23 | Robert Vidlund | Apparatus and methods for alignment and deployment of intracardiac devices |
EP3656353A1 (en) | 2013-10-28 | 2020-05-27 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems for delivering the same |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US9913715B2 (en) | 2013-11-06 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular leak sealing mechanism |
US20150122687A1 (en) | 2013-11-06 | 2015-05-07 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage |
CR20160240A (en) | 2013-11-11 | 2016-08-04 | Edwards Lifesciences Cardiaq Llc | SYSTEMS AND METHODS FOR THE MANUFACTURE OF THE FRAME OF A CANNULA |
US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
WO2015120122A2 (en) | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
AU2015229708B2 (en) | 2014-03-10 | 2019-08-15 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US9549816B2 (en) | 2014-04-03 | 2017-01-24 | Edwards Lifesciences Corporation | Method for manufacturing high durability heart valve |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
CA2914094C (en) | 2014-06-20 | 2021-01-05 | Edwards Lifesciences Corporation | Surgical heart valves identifiable post-implant |
USD867594S1 (en) | 2015-06-19 | 2019-11-19 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US10195026B2 (en) | 2014-07-22 | 2019-02-05 | Edwards Lifesciences Corporation | Mitral valve anchoring |
US10058424B2 (en) | 2014-08-21 | 2018-08-28 | Edwards Lifesciences Corporation | Dual-flange prosthetic valve frame |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
EP3242630A2 (en) | 2015-01-07 | 2017-11-15 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
WO2016115375A1 (en) | 2015-01-16 | 2016-07-21 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
CA2975294A1 (en) | 2015-02-05 | 2016-08-11 | Tendyne Holdings, Inc. | Expandable epicardial pads and devices and methods for delivery of same |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
US10792471B2 (en) | 2015-04-10 | 2020-10-06 | Edwards Lifesciences Corporation | Expandable sheath |
US10327896B2 (en) | 2015-04-10 | 2019-06-25 | Edwards Lifesciences Corporation | Expandable sheath with elastomeric cross sectional portions |
US10010417B2 (en) | 2015-04-16 | 2018-07-03 | Edwards Lifesciences Corporation | Low-profile prosthetic heart valve for replacing a mitral valve |
CA2983002C (en) | 2015-04-16 | 2023-07-04 | Tendyne Holdings, Inc. | Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves |
US10064718B2 (en) | 2015-04-16 | 2018-09-04 | Edwards Lifesciences Corporation | Low-profile prosthetic heart valve for replacing a mitral valve |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
CN104840274B (en) * | 2015-05-18 | 2017-08-29 | 周宏� | Artificial Intervention valve is adapted to mounting ring |
WO2017004377A1 (en) | 2015-07-02 | 2017-01-05 | Boston Scientific Scimed, Inc. | Adjustable nosecone |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
WO2017004369A1 (en) | 2015-07-02 | 2017-01-05 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
CR20170597A (en) | 2015-07-02 | 2018-04-20 | Edwards Lifesciences Corp | INTEGRATED HYBRID HEART VALVES |
ITUB20152409A1 (en) | 2015-07-22 | 2017-01-22 | Sorin Group Italia Srl | VALVE SLEEVE FOR VALVULAR PROSTHESIS AND CORRESPONDING DEVICE |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
EP3344158B1 (en) | 2015-09-02 | 2023-03-01 | Edwards Lifesciences Corporation | Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
US10470876B2 (en) | 2015-11-10 | 2019-11-12 | Edwards Lifesciences Corporation | Transcatheter heart valve for replacing natural mitral valve |
US10376364B2 (en) | 2015-11-10 | 2019-08-13 | Edwards Lifesciences Corporation | Implant delivery capsule |
ES2777609T3 (en) | 2015-12-03 | 2020-08-05 | Tendyne Holdings Inc | Framework Features for Prosthetic Mitral Valves |
CN108366859B (en) | 2015-12-28 | 2021-02-05 | 坦迪尼控股股份有限公司 | Atrial capsular bag closure for prosthetic heart valves |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10179043B2 (en) | 2016-02-12 | 2019-01-15 | Edwards Lifesciences Corporation | Prosthetic heart valve having multi-level sealing member |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
CA3216740A1 (en) | 2016-03-24 | 2017-09-28 | Edwards Lifesciences Corporation | Delivery system for prosthetic heart valve |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
EP3468480B1 (en) | 2016-06-13 | 2023-01-11 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
WO2017218817A1 (en) * | 2016-06-15 | 2017-12-21 | Children's National Medical Center | Expanding-collapsing sewing ring to facilitate ventricular assist device implantation and explantation |
WO2018005779A1 (en) | 2016-06-30 | 2018-01-04 | Tegels Zachary J | Prosthetic heart valves and apparatus and methods for delivery of same |
US11065116B2 (en) | 2016-07-12 | 2021-07-20 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US11096781B2 (en) | 2016-08-01 | 2021-08-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US10463484B2 (en) | 2016-11-17 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic heart valve having leaflet inflow below frame |
US10973631B2 (en) | 2016-11-17 | 2021-04-13 | Edwards Lifesciences Corporation | Crimping accessory device for a prosthetic valve |
US10603165B2 (en) | 2016-12-06 | 2020-03-31 | Edwards Lifesciences Corporation | Mechanically expanding heart valve and delivery apparatus therefor |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
CA3060663C (en) | 2017-04-28 | 2024-03-26 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
US11135056B2 (en) | 2017-05-15 | 2021-10-05 | Edwards Lifesciences Corporation | Devices and methods of commissure formation for prosthetic heart valve |
EP3630013A4 (en) | 2017-05-22 | 2020-06-17 | Edwards Lifesciences Corporation | Valve anchor and installation method |
US20210401571A9 (en) | 2017-05-31 | 2021-12-30 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10869759B2 (en) | 2017-06-05 | 2020-12-22 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US11026785B2 (en) | 2017-06-05 | 2021-06-08 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
EP3634311A1 (en) | 2017-06-08 | 2020-04-15 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
CN110831547B (en) | 2017-06-21 | 2022-07-15 | 爱德华兹生命科学公司 | Double-wire limited expansion heart valve |
WO2019014473A1 (en) | 2017-07-13 | 2019-01-17 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US10918473B2 (en) | 2017-07-18 | 2021-02-16 | Edwards Lifesciences Corporation | Transcatheter heart valve storage container and crimping mechanism |
EP3661458A1 (en) | 2017-08-01 | 2020-06-10 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
KR102617878B1 (en) | 2017-08-11 | 2023-12-22 | 에드워즈 라이프사이언시스 코포레이션 | Sealing elements for artificial heart valves |
US11083575B2 (en) | 2017-08-14 | 2021-08-10 | Edwards Lifesciences Corporation | Heart valve frame design with non-uniform struts |
US10932903B2 (en) | 2017-08-15 | 2021-03-02 | Edwards Lifesciences Corporation | Skirt assembly for implantable prosthetic valve |
EP3668449A1 (en) | 2017-08-16 | 2020-06-24 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US10898319B2 (en) | 2017-08-17 | 2021-01-26 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10973628B2 (en) | 2017-08-18 | 2021-04-13 | Edwards Lifesciences Corporation | Pericardial sealing member for prosthetic heart valve |
US10722353B2 (en) | 2017-08-21 | 2020-07-28 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
JP7291124B2 (en) | 2017-08-28 | 2023-06-14 | テンダイン ホールディングス,インコーポレイテッド | Heart valve prosthesis with tethered connections |
US10973629B2 (en) | 2017-09-06 | 2021-04-13 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11147667B2 (en) | 2017-09-08 | 2021-10-19 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
WO2019144071A1 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
JP7055882B2 (en) | 2018-01-19 | 2022-04-18 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Guidance mode indwelling sensor for transcatheter valve system |
CN111565678B (en) | 2018-01-23 | 2023-07-07 | 爱德华兹生命科学公司 | Prosthetic valve holders, systems, and methods |
US11147668B2 (en) | 2018-02-07 | 2021-10-19 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
US11439732B2 (en) | 2018-02-26 | 2022-09-13 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
US11318011B2 (en) | 2018-04-27 | 2022-05-03 | Edwards Lifesciences Corporation | Mechanically expandable heart valve with leaflet clamps |
US11229517B2 (en) | 2018-05-15 | 2022-01-25 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
KR20210082188A (en) | 2018-10-19 | 2021-07-02 | 에드워즈 라이프사이언시스 코포레이션 | Artificial heart valve with non-cylindrical frame |
WO2020123486A1 (en) | 2018-12-10 | 2020-06-18 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
CN113873973B (en) | 2019-03-26 | 2023-12-22 | 爱德华兹生命科学公司 | prosthetic heart valve |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
EP3831343B1 (en) | 2019-12-05 | 2024-01-31 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
WO2021126778A1 (en) | 2019-12-16 | 2021-06-24 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
US11951002B2 (en) | 2020-03-30 | 2024-04-09 | Tendyne Holdings, Inc. | Apparatus and methods for valve and tether fixation |
WO2022039853A1 (en) | 2020-08-19 | 2022-02-24 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
CN113397652B (en) * | 2021-05-06 | 2022-07-22 | 深圳脉动医学技术有限公司 | Minimally invasive vascular embolism removing device for cardiovascular surgery |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1180087B (en) * | 1964-03-26 | 1964-10-22 | Dr Wolfgang Seidel | Prosthetic heart valve |
US3491376A (en) * | 1965-10-06 | 1970-01-27 | Donald P Shiley | Heart valve with separate suturing ring sub-assembly |
US3524202A (en) * | 1967-05-19 | 1970-08-18 | Harry W Cromie | Prosthetic heart valve |
US3725961A (en) * | 1970-12-29 | 1973-04-10 | Baxter Laboratories Inc | Prosthetic heart valve having fabric suturing element |
US3691567A (en) * | 1971-05-07 | 1972-09-19 | Baxter Laboratories Inc | Prosthetic heart valve having a pair of support rings of dissimilar material |
US3763548A (en) * | 1972-03-17 | 1973-10-09 | L Anderson | Method of mounting a rotatable suturing member on a device |
US4197593A (en) * | 1978-03-03 | 1980-04-15 | Kastec Corporation | Rotatably positionable heart valve and method |
US4254508A (en) * | 1979-07-30 | 1981-03-10 | Carbomedics, Inc. | Bileaflet heart valve with improved pivot |
US4308624A (en) * | 1979-08-07 | 1982-01-05 | Hemex, Inc. | Heart valve prosthesis |
-
1983
- 1983-01-17 US US06/458,618 patent/US4535483A/en not_active Expired - Lifetime
- 1983-12-16 NO NO834641A patent/NO834641L/en unknown
- 1983-12-20 AT AT83307756T patent/ATE27542T1/en not_active IP Right Cessation
- 1983-12-20 EP EP83307756A patent/EP0119357B1/en not_active Expired
- 1983-12-20 DE DE8383307756T patent/DE3371862D1/en not_active Expired
-
1984
- 1984-01-04 CA CA000444640A patent/CA1211254A/en not_active Expired
- 1984-01-05 AU AU23104/84A patent/AU557515B2/en not_active Ceased
- 1984-01-13 BR BR8400148A patent/BR8400148A/en unknown
- 1984-01-16 IN IN24/MAS/84A patent/IN159219B/en unknown
- 1984-01-16 ES ES528890A patent/ES8601675A1/en not_active Expired
- 1984-01-16 DK DK17584A patent/DK17584A/en not_active Application Discontinuation
- 1984-01-17 JP JP59006205A patent/JP2608869B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE27542T1 (en) | 1987-06-15 |
EP0119357B1 (en) | 1987-06-03 |
AU2310484A (en) | 1984-07-19 |
ES528890A0 (en) | 1985-11-01 |
JP2608869B2 (en) | 1997-05-14 |
DK17584A (en) | 1984-07-18 |
DK17584D0 (en) | 1984-01-16 |
EP0119357A1 (en) | 1984-09-26 |
AU557515B2 (en) | 1986-12-24 |
BR8400148A (en) | 1984-08-21 |
ES8601675A1 (en) | 1985-11-01 |
NO834641L (en) | 1984-07-18 |
US4535483A (en) | 1985-08-20 |
JPS59137051A (en) | 1984-08-06 |
IN159219B (en) | 1987-04-11 |
DE3371862D1 (en) | 1987-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1211254A (en) | Suture rings for heart valves | |
US5147391A (en) | Bioprosthetic heart valve with semi-permeable commissure posts and deformable leaflets | |
CA2079339C (en) | Mechanical heart valve with compliant sewing ring | |
US5178633A (en) | Suture ring for heart valve prosthesis | |
US5843179A (en) | Suture guard for prosthetic heart valve | |
EP0477325B1 (en) | Bioprosthetic heart valve with elastic commissures | |
US5397346A (en) | Prosthetic heart valve with sewing ring | |
US5776188A (en) | Direct suture orifice for mechanical heart valve | |
US6348068B1 (en) | Multi-filament valve stent for a cardisc valvular prosthesis | |
CA1115455A (en) | Inherent shape memory coupling for heart valve | |
US5071431A (en) | Suture rings for heart valves and method of securing suture rings to heart valves | |
US5766240A (en) | Rotatable suturing ring for prosthetic heart valve | |
US6217611B1 (en) | Modular heart valve prothesis | |
US3725961A (en) | Prosthetic heart valve having fabric suturing element | |
US6790237B2 (en) | Medical stent with a valve and related methods of manufacturing | |
US20020055773A1 (en) | Polymer heart valve with insert molded fabric sewing cuff | |
US5976183A (en) | Sewing ring for heart valve prosthesis | |
CN116616956A (en) | Artificial implantation heart valve | |
JPS5813185B2 (en) | Suture member and method of attaching it to a member having an outer cylindrical portion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |